当前位置: X-MOL 学术Clin. Proteom. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The use of proteomics for blood biomarker research in premature infants: a scoping review
Clinical Proteomics ( IF 2.8 ) Pub Date : 2021-04-14 , DOI: 10.1186/s12014-021-09316-y
Natasha Letunica , Tengyi Cai , Jeanie L. Y. Cheong , Lex W. Doyle , Paul Monagle , Vera Ignjatovic

Over the last decade, the use of proteomics in the setting of prematurity has increased and has enabled researchers to successfully identify biomarkers for an array of associated morbidities. The objective of this scoping review was to identify the existing literature, as well as any knowledge gaps related to proteomic biomarker discoveries in the setting of prematurity. A scoping review was conducted using PubMed, Embase and Medline databases following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The study selection process yielded a total of 700 records, of which 13 studies were included in this review. Most studies used a tandem Mass Spectrometry (MS/MS) proteomics approach to identify key biomarkers. The corresponding studies identified proteins associated with retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), necrotising enterocolitis (NEC), late onset sepsis (LOS) and gestational age. This scoping review demonstrates the limited use of proteomics to identify biomarkers associated with severe complications of prematurity. Further research is warranted to identify biomarkers of other important morbidities associated with prematurity, such as intraventricular haemorrhage (IVH) and cerebral palsy, and to investigate the mechanisms associated with these outcomes.

中文翻译:

蛋白质组学在早产儿血液生物标志物研究中的应用:范围回顾

在过去的十年中,蛋白质组学在早产情况中的使用有所增加,并使研究人员能够成功地识别一系列相关发病率的生物标志物。范围界定审查的目的是确定现有文献以及在早产情况下与蛋白质组生物标志物发现相关的任何知识空白。遵循系统评价的首选报告项目和作用域评价的元分析扩展(PRISMA-ScR)指南,使用PubMed,Embase和Medline数据库进行了作用域评价。研究选择过程总共产生了700条记录,其中13项研究包括在本评价中。大多数研究使用串联质谱(MS / MS)蛋白质组学方法来鉴定关键的生物标志物。相应的研究确定了与早产儿视网膜病变(ROP),支气管肺发育不良(BPD),坏死性小肠结肠炎(NEC),迟发性败血症(LOS)和胎龄相关的蛋白质。这项范围界定的审查表明,蛋白质组学在识别与早产严重并发症相关的生物标志物方面的用途有限。有必要进行进一步的研究来鉴定与早产相关的其他重要疾病的生物标志物,例如脑室内出血(IVH)和脑瘫,并研究与这些结果相关的机制。这项范围界定的审查表明,蛋白质组学在识别与早产严重并发症相关的生物标志物方面的用途有限。有必要进行进一步的研究来鉴定与早产相关的其他重要疾病的生物标志物,例如脑室内出血(IVH)和脑瘫,并研究与这些结果相关的机制。这项范围界定的审查表明,蛋白质组学在识别与早产严重并发症相关的生物标志物方面的用途有限。有必要进行进一步的研究来鉴定与早产相关的其他重要疾病的生物标志物,例如脑室内出血(IVH)和脑瘫,并研究与这些结果相关的机制。
更新日期:2021-04-15
down
wechat
bug